GlassScriptPhysician profile
Jason Liu
NPI 1952821738
$35,170.51
in general payments reported to CMS, 2019-2025
39 companies · $12K in 2025
The $12K reported for 2025 was more than what 95% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $696 · 2022: $1,962 · 2023: $7,191 · 2024: $13K · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $15K · Food and Beverage: $14K · Grant: $2,294 · Consulting Fee: $1,000 · Education: $240.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $14,911.20 |
| Food and Beverage | $14,067.39 |
| Grant | $2,294.12 |
| Consulting Fee | $1,000.00 |
| Education | $239.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $9,513.16 | 2022-2025 | Perclose Proglide, Optis, Xact |
| Boston Scientific Corporation | $6,013.08 | 2022-2025 | Ranger, Jetstream Sc, Synergy |
| Edwards Lifesciences Corporation | $3,548.87 | 2022-2025 | Pascal, Sapien 3 Ultra Resilia |
| Philips North America LLC | $3,248.83 | 2023-2024 | (9520) Igt Devices Undivided, (6554) Peripheral Vascular Undivided |
| Medtronic, INC. | $3,156.44 | 2021-2025 | Corevalve Evolut R, Onyx Frontier, Azure Xt Dr Mri Surescan |
| Cagent Vascular INC | $3,016.65 | 2025 | Serrantor |
| Abiomed | $873.67 | 2023-2025 | Impella |
| Terumo Medical Corporation | $764.90 | 2024-2025 | Glidewire, R2p Misago |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $493.19 | 2021-2025 | Lifevest |
| Angiodynamics, INC. | $483.07 | 2022-2025 | Alphavac |
| Teleflex LLC | $395.32 | 2023-2025 | Manta, Guideliner |
| Inari Medical, INC. | $327.74 | 2022-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Cardiva Medical, INC. | $299.68 | 2023-2024 | Savvywire, Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 6/7f Vcs |
| Sanofi-Aventis U.S. LLC | $271.21 | 2022-2023 | |
| Novartis Pharmaceuticals Corporation | $268.37 | 2022-2024 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $252.27 | 2021-2024 | |
| W. L. Gore & Associates, INC. | $235.68 | 2021-2024 | Gore Cardioform Septal Occluder |
| Ets Wound Care LLC | $190.98 | 2024 | Mirragen Advanced Wound Matrix |
| Astrazeneca Pharmaceuticals LP | $178.93 | 2021-2025 | Wainua |
| Shockwave Medical, INC | $171.46 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Amgen INC. | $161.98 | 2023-2025 | Repatha, Repatha |
| Esperion Therapeutics, INC. | $143.00 | 2021-2025 | Nexletol |
| Avinger INC. | $143.00 | 2023 | Pantheris |
| Astellas Pharma US INC | $141.70 | 2021 | |
| Penumbra, INC. | $130.43 | 2024 | Indigo System |
| Janssen Pharmaceuticals, INC | $128.06 | 2022-2024 | Xarelto |
| Impulse Dynamics (USA) INC. | $109.83 | 2022-2023 | Optimizer |
| Stryker Corporation | $106.53 | 2023 | Spy-Phi System |
| Chiesi USA, INC. | $81.53 | 2021-2022 | |
| Cvrx, INC. | $78.31 | 2024-2025 | Barostim Neo System |
| Bridgebio Pharma, INC. | $46.16 | 2025 | Attruby |
| Bayer Healthcare Pharmaceuticals INC. | $39.72 | 2025 | |
| Procyrion, INC. | $38.94 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.59 | 2024 | Jardiance |
| Cordis US Corp. | $24.37 | 2023 | Outback Elite |
| Contego Medical, INC | $18.50 | 2024 | |
| Lantheus Medical Imaging, INC. | $17.20 | 2023 | Definity |
| Heartflow, INC. | $17.12 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $14.04 | 2023 | Eliquis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Liu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.